QQQ   426.84 (+0.23%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.39 (+0.83%)
T   16.19 (+0.43%)
F   12.12 (+0.66%)
MU   113.67 (-2.29%)
GE   156.63 (+0.62%)
CGC   7.84 (+20.80%)
DIS   113.57 (+0.56%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
QQQ   426.84 (+0.23%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.39 (+0.83%)
T   16.19 (+0.43%)
F   12.12 (+0.66%)
MU   113.67 (-2.29%)
GE   156.63 (+0.62%)
CGC   7.84 (+20.80%)
DIS   113.57 (+0.56%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
QQQ   426.84 (+0.23%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.39 (+0.83%)
T   16.19 (+0.43%)
F   12.12 (+0.66%)
MU   113.67 (-2.29%)
GE   156.63 (+0.62%)
CGC   7.84 (+20.80%)
DIS   113.57 (+0.56%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
QQQ   426.84 (+0.23%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.39 (+0.83%)
T   16.19 (+0.43%)
F   12.12 (+0.66%)
MU   113.67 (-2.29%)
GE   156.63 (+0.62%)
CGC   7.84 (+20.80%)
DIS   113.57 (+0.56%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
OTCMKTS:APVS

Applied Visual Sciences (APVS) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
APVS stock logo

About Applied Visual Sciences Stock (OTCMKTS:APVS)

Applied Visual Sciences, Inc., a software technology company, designs and develops computer-vision detection solutions based on image processing science for aviation/homeland security and healthcare markets. It utilizes imaging technologies and analytics to create integrated information management technology products and services that address problems for corporations and governmental agencies. The company offers PinPoint, an intelligent computer-vision automated target recognition technology for the detection of guns, explosives, and other threat items contained in baggage in the airport environment or for building security applications; and Signature Mapping platform technology for use in the imaging field of diagnostic radiology and pathology. It also provides Signature Mapping Detection System, an automated hardware-software laboratory solution used to operate various infectious disease applications through multi-threaded detection algorithms. In addition, the company offers Signature Mapping Tuberculosis Detection software, an automated hardware and software technology platform; and Signature Mapping Breast Cancer Detection, a breast cancer detection solution. Applied Visual Sciences, Inc. markets its products through direct sales and indirect distribution channels worldwide. The company was formerly known as Guardian Technologies International, Inc. and changed its name to Applied Visual Sciences, Inc. in July 2010. Applied Visual Sciences, Inc. was founded in 1989 and is based in Leesburg, Virginia.

APVS Stock News Headlines

APVS.PK - | Stock Price & Latest News | Reuters
APVS.PQ - | Stock Price & Latest News | Reuters
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
Applied Visual Sciences Inc (APVS)
Applied Visual Sciences Inc.
Applied Visual Sciences, Inc.
See More Headlines
Receive APVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Visual Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Aerospace
Industry
Computers, peripherals, & software
Sub-Industry
N/A
Current Symbol
OTCMKTS:APVS
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. William J. Donovan (Age 72)
    Chairman, CEO & Secretary
    Comp: $271k
  • Mr. Gregory E. Hare (Age 70)
    Chief Financial Officer, Treasurer and Corporate Secretary
    Comp: $200k
  • Mr. Sean W. Kennedy (Age 72)
    Chief Technology Officer
    Comp: $208k
  • Mr. Carl C. Smith Jr. (Age 75)
    Vice President of Business Development & Security
    Comp: $160k

APVS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Applied Visual Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Visual Sciences investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

How do I buy shares of Applied Visual Sciences?

Shares of APVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:APVS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners